← Back to Search

Hemostasis for Radial Artery Injury (EASY-RAO Trial)

N/A

Waitlist Available

Research Sponsored by Olivier F. Bertrand

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

any patients referred for diagnostic angiography and possible percutaneous coronary intervention (PCI)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up throughout intervention, up to 180 minutes

Awards & highlights

EASY-RAO Trial Summary

This trial aims to show that a dual artery compression device is better than a standard radial artery-only hemostasis device.

EASY-RAO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

EASY-RAO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ throughout intervention, up to 180 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~throughout intervention, up to 180 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout intervention, up to 180 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of RAO after transradial approach (TRA) at hospital discharge

Secondary outcome measures

Nursing involvement in hemostasis management for sensitivity analysis on cost assessment

Patient comfort during hemostasis as assessed on a visual scale

Percentage of radial artery patent-hemostasis during hemostasis

+1 more

EASY-RAO Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Dual Artery CompressionExperimental Treatment1 Intervention

time to hemostasis and incidence of radial artery occlusion will be monitored while using a dual artery compression device (Terry-2-band) to achieve hemostasis.

Group II: Radial Artery-OnlyActive Control1 Intervention

time to hemostasis and incidence of radial artery occlusion will be monitored while using the device currently approved by the institution (Hemo-Stop) and following institutional protocols for hemostasis.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Olivier F. BertrandLead Sponsor

2 Previous Clinical Trials

502 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we recruiting participants for this experiment at the moment?

"Indeed, the trial is still actively looking for participants. According to clinicaltrials.gov, the posting went up on June 18th, 2020 and was last edited January 28th, 2022."

Answered by AI

Could you please tell me how many people are currently participating in this clinical trial?

"That is correct, the information available on clinicaltrials.gov affirms that this study is presently recruiting patients. The first posting for this trial was on 6/18/2020 with the most recent update being on 1/28/2022. They are searching for 100 individuals to participate at 1 site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dual Artery Compression vs. Radial Artery-Only Hemostasis: Impact on Radial Artery Occlusion (EASY-RAO)

Olivier F. Bertrand 2020. "Dual Artery Compression vs. Radial Artery-Only Hemostasis: Impact on Radial Artery Occlusion (EASY-RAO)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04439513.